Group B streptococcal PCR testing in comparison to culture for diagnosis of late onset bacteraemia and meningitis in infants aged 7–90 days: a multi-centre diagnostic accuracy study
- 1 March 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 36 (7) , 1317-1324
Abstract
The aim of this study was to compare an in-house real-time PCR assay, with bacterial culture as the reference, for the diagnosis of late onset group B Streptococcal (GBS) disease. This was a retrospective review. All children aged 7–90 days presenting to four paediatric centres that had a blood or CSF sample tested by GBS PCR were included. Of 7,686 blood and 2,495 cerebrospinal fluid (CSF) samples from patients of all ages received for PCR testing, 893 and 859 samples were eligible for the study, respectively. When compared to culture, the sensitivity of blood PCR was 65% (13/20) in comparison to the CSF PCR test which was 100% (5/5). Ten of 23 PCR-positive blood samples and 17 of 22 PCR-positive CSF samples were culture negative. The median threshold Ct values for culture-positive/PCR-positive CSF samples was lower than that of culture-negative/PCR-positive CSF samples (p = 0.08). Clinical details of 17 available cases that were culture negative/PCR positive were reviewed; seven were deemed to be definite cases, eight were probable and two were possible. The results showed that detection of GBS by PCR is useful for CSF samples from infants aged 7–90 days with suspected meningitis; however, analysis of blood samples by PCR is of limited value as a routine screening test for late onset GBS sepsis and should not replace bacterial culture.Keywords
This publication has 15 references indexed in Scilit:
- Development and performance evaluation of a recombinase polymerase amplification assay for the rapid detection of group B streptococcusBMC Microbiology, 2016
- Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trialThe Lancet Infectious Diseases, 2016
- Accuracy of a rapid real-time polymerase chain reaction assay for diagnosis of group B Streptococcus colonization in a cohort of HIV-infected pregnant womenThe Journal of Maternal-Fetal & Neonatal Medicine, 2016
- The Protective Value of Maternal Group BStreptococcusAntibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal SeraClinical Infectious Diseases, 2016
- Real-time polymerase chain reaction and culture in the diagnosis of invasive group B streptococcal disease in infants: a retrospective studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2015
- Incidence, Etiology, and Outcome of Bacterial Meningitis in Infants Aged <90 Days in the United Kingdom and Republic of Ireland: Prospective, Enhanced, National Population-Based SurveillanceClinical Infectious Diseases, 2014
- An overview of global GBS epidemiologyVaccine, 2013
- Non-culture detection of Streptococcus agalactiae (Lancefield group B Streptococcus) in clinical samples by real-time PCRJournal of Medical Microbiology, 2012
- Molecular Assays in the Diagnosis of Neonatal Sepsis: A Systematic Review and Meta-analysisPediatrics, 2011
- Group B Streptococcal Disease in the Era of Intrapartum Antibiotic ProphylaxisNew England Journal of Medicine, 2000